Association study of the -866G/A UCP2 gene promoter polymorphism with type 2 diabetes and obesity in a tehran population: A case control study

Archives of Iranian Medicine

Volumn 13, Issue 5, 2010, Pages 384-390

  Heidari, Javad ^a   Akrami, Seyed Mohammad ^a,b   Heshmat, Ramin ^a   Amiri, Parvin ^a   Fakhrzadeh, Hossein ^a   Pajouhi, Mohammad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

866G A polymorphism; Iranian; Obesity; PCR RFLP; Type 2 diabetes; Uncoupling protein 2

Indexed keywords

ADENINE; GUANINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; UNCOUPLING PROTEIN 2;

ADULT; AGED; ARTICLE; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; ION CHANNELS; IRAN; LOGISTIC MODELS; MALE; MIDDLE AGED; MITOCHONDRIAL PROTEINS; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; YOUNG ADULT;

EID: 78149259769     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Gimeno RE, Dembski M, Weng X, Deng N, Shyjan AW, Gimeno CJ, et al. Cloning and characterization of an uncoupling protein homolog: A potential molecular mediator of human thermogenesis. Diabetes. 1997; 46: 900-906.
2. Fleury C, Neverova M, Collins S, Raimbault S, Champigny O, Levi-Meyrueis C, et al. Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet. 1997; 15: 269-272.
3. Esterbauer H, Schneitler C, Oberkofler H, Ebenbichler C, Paulweber B, Sandhofer F, et al. A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middleaged humans. Nat Genet. 2001; 28: 178-183.
4. Krempler F, Esterbauer H, Weitgasser R, Ebenbichler C, Patsch JR, Miller K, et al. A functional polymorphism in the promoter of UCP2 enhances obesity risk but reduces type 2 diabetes risk in obese middle-aged humans. Diabetes. 2002; 51: 3331-3335.
5. Sesti G, Cardellini M, Marini MA, Frontoni S, D'Adamo M, Del Guerra S, et al. A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. Diabetes. 2003; 52: 1280-1283.
6. Schauble N, Geller F, Siegfried W, Goldschmidt H, Remschmidt H, Hinney A, et al. No evidence for involvement of the promoter polymorphism -866 G/A of the UCP2 gene in childhood-onset obesity in humans. Exp Clin Endocrinol Diabetes. 2003; 111: 73-76.
7. Ji Q, Ikegami H, Fujisawa T, Kawabata Y, Ono M, Nishino M, et al. A common polymorphism of uncoupling protein 2 gene is associated with hypertension. J Hypertens. 2004; 22: 97-102.
8. Zhang B, Tanaka H, Saku K. Simple and rapid detection of uncoupling protein-2 - 866G/A polymorphism by mutagenically separated polymerase chain reaction. Clin Chim Acta. 2004; 344: 205-210.
9. Zhang CY, Baffy G, Perret G, Krauss S, Peroni O, Grujic D, et al. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, β cell dysfunction, and type 2 diabetes. Cell. 2001; 105: 745-755.
10. Akrami SM, Heidari J, Heshmat R, Amiri P, Fakhrzadeh H, Pajouhi M. The common -866G/A polymorphism of the UCP2 gene in healthy Iranians compared with world populations. Hum Biol. 2007; 78: 103-110.
11. Fakhrzadeh H, Ghotbi S, Pourebrahim R, Heshmat R, Nouri M, Shafaee A, et al. Plasma homocysteine concentration and blood pressure in healthy Iranian adults: The Tehran Homocysteine Survey (2003-2004). 2005; 28: 869-876.
12. Fakhrzadeh H, Ghotbi S, Pourebrahim R, Nouri M, Heshmat R, Bandarian F, et al. Total plasma homocysteine, folate, and vitamin B12 status in healthy Iranian adults: The Tehran homocysteine survey (2003-2004)/ A cross-sectional population based study. BMC Public Health. 2006; 13: 29.
13. Heshmat R, Fakhrzadeh H, Pour-Ebrahim R, Nouri M, Alaeddini F. Cardiovascular risk factors study in the inhabitants of Tehran University of Medical Sciences population lab: Statistical design and sampling. Iran J Diabetes Lipid Disord. 2004; 3: 21-25
14. Miller S, Dykes D, Polesky H. Simple salting out procedure for extracting DNA from nucleated cells. Nucleic Acid Res. 1988; 16: 1215.
15. D'Adamo M, Perego L, Cardellini M, Marini MA, Frontoni S, Andreozzi F, et al. The -866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes. Diabetes. 2004; 53: 1905-1910.
16. Mancini FP, Sabatino L, Colantuoni V, Pasanisi F, Finelli C, Contaldo F, et al. Variants of uncoupling protein-2 gene and obesity: interaction with peroxisome proliferator-activated receptorgamma 2. Clin Endocrinol (Oxf). 2003; 59: 817-822.
17. Bulotta A, Ludovico O, Coco A, Di Paola R, Quattrone A, Carella M, et al. The common -866G/A polymorphism in the promoter region of the UCP-2 gene is associated with reduced risk of type 2 diabetes in Caucasians from Italy. J Clin Endocrinol Metab. 2005; 90: 1176-1180.
18. Dalgaard LT, Andersen G, Larsen LH, Sorensen TI, Andersen T, Drivsholm T, et al. Mutational analysis of the UCP2 core promoter and relationships of variants with obesity. Obes Res. 2003; 11: 1420-1427.
19. Otabe S, Clement K, Rich N, Warden C, Pecqueur C, Neverova M, et al. Mutation screening of the human UCP2 gene in normoglycemic and NIDDM morbidly obese patients: lack of association between new UCP2 polymorphisms and obesity in French Caucasians. Diabetes. 1998; 47: 840-842.
20. Maestrini S, Podesta F, Di Blasio AM, Savia G, Brunani A, Tagliaferri A, et al. Lack of association between UCP2 gene polymorphisms and obesity phenotype in Italian Caucasians. J Endocrinol Invest. 2003; 26: 985-990.
21. Goldberg IJ. Clinical review 124: Diabetic dyslipidemia: causes and consequences. J Clin Endocrinol Metab. 2001; 86: 965-971.
22. Reis AF, Dubois-Laforgue D, Bellanne-Chantelot C, Timsit J, Velho G. A polymorphism in the promoter of UCP2 gene modulates lipid levels in patients with type 2 diabetes. Mol Genet Metab. 2004; 82: 339-344.
23. Cha MH, Kim IC, Kim KS, Kang BK, Choi SM, Yoon Y. Association of UCP2 and UCP3 gene polymorphisms with serum high-density lipoprotein cholesterol among Korean women. Metabolism. 2007; 56: 806-813.